Open Access Open Access  Restricted Access Subscription or Fee Access

Advancements in Understanding and Managing Myocardial Infarction: A Comprehensive Review

Rupinderjit Kaur

Abstract


A myocardial infarction, often known as a heart attack, is a severe health issue characterized by a sudden reduction in blood flow to a part of the heart muscle, leading to the impairment or demise of cardiac cells. This occurs when the coronary arteries, responsible for delivering oxygenated blood to the heart, become blocked, typically due to the formation of a clot within them. The clinical manifestation of a myocardial infarction involves intense chest pain or discomfort, frequently extending to the left arm, neck, jaw, or back. Additional symptoms may encompass shortness of breath, sweating, nausea, and lightheadedness. Prompt medical attention is crucial to minimize the extent of damage to the heart muscle and improve the chances of survival. The main factor behind myocardial infarction is atherosclerosis, a condition marked by the accumulation of fatty deposits (plaques) on the inner walls of the coronary arteries. These plaques have the potential to rupture, resulting in the creation of blood clots that impede the flow of blood. Various risk factors contribute to the development of atherosclerosis, including age, gender, family history, smoking, high blood pressure, diabetes, and elevated cholesterol levels. The diagnosis of myocardial infarction involves a combination of clinical evaluation, electrocardiogram (ECG or EKG) findings, blood tests measuring cardiac biomarkers, and imaging studies such as echocardiography. Immediate intervention is crucial, and treatment options may include medications to dissolve clots, restore blood flow, and alleviate symptoms. In advanced instances, invasive interventions such as angioplasty and the placement of stents or coronary artery bypass surgery might be required to reinstate adequate blood flow to the heart. Secondary prevention strategies focus on lifestyle modifications and the management of risk factors to prevent recurrent events. Cardiac rehabilitation programs, dietary changes, regular exercise, and medications are essential components of long-term care for individuals who have experienced a myocardial infarction. In summary, a myocardial infarction signifies a serious cardiovascular incident with potential life-threatening outcomes. Timely recognition, emergency medical intervention, and comprehensive post-event management are crucial for improving outcomes and preventing further occurrences of this cardiac condition.


Full Text:

PDF

References


Roberts, R., & Morrow, D. A. (2019). Myocardial infarction: the cell biology of coronary thrombosis. Journal of the American College of Cardiology, 73(2), 200–209.

Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., ... & Lisheng, L. (2004). Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study. The Lancet, 364(9438), 937–952.

Bhatnagar, P., Wickramasinghe, K., Wilkins, E., Townsend, N., (2018). Trends in the epidemiology of cardiovascular disease in the UK. Heart, 104(13), 1157–1163.

Thygesen, K., Alpert, J. S., Jaffe, A. S., Chaitman, B. R., Bax, J. J., Morrow, D. A., & White, H. D. (2018). Fourth universal definition of myocardial infarction (2018). European Heart Journal, 40(3), 237–269.

Mueller, C., & Apple, F. S. (2018). Use of high-sensitivity cardiac troponin for the exclusion of inducible myocardial ischemia: a cohort study. Annals of Internal Medicine, 169(11), 751–762.

Ibanez, B., James, S., Agewall, S., Antunes, M. J., Bucciarelli-Ducci, C., Bueno, H., ... & Bugiardini, R. (2018). 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). European Heart Journal, 39(2), 119–177.

O'Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K., de Lemos, J. A., ... & Stevenson, W. G. (2013). 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation, 127(4), e362–e425.

Anderson, L., Oldridge, N., Thompson, D. R., Zwisler, A. D., Rees, K., Martin, N., ... & Taylor, R. S. (2016). Exercise-based cardiac rehabilitation for coronary heart disease: Cochrane systematic review and meta-analysis. Journal of the American College of Cardiology, 67(1), 1–12.

Madonna, R., Cadeddu, C., Deidda, M., Mele, D., Monte, I. D., Novo, G., ... & Frati, G. (2019). Improving cell therapy for myocardial infarction. Current Pharmaceutical Design, 25(35), 3792–3807.

Sengupta, P. P., Kulkarni, H., Narula, J., & Sengupta, P. P. (2020). Artificial intelligence in cardiovascular medicine: the role of precision medicine. Nature Reviews Cardiology, 17(7), 1–15.




DOI: https://doi.org/10.37628/ijcn.v9i2.2391

Refbacks

  • There are currently no refbacks.